Combined first trimester nuchal translucency and second trimester biochemical screening tests among normal pregnancies

Prenatal Diagnosis

Volumn 20, Issue 10, 2000, Pages 781-784

  Herman, A ^a,b   Weinraub, Z ^a   Dreazen, E ^a   Arieli, S ^a   Rozansky, S ^a   Bukovsky, I ^a   Maymon, R ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Combined risk; Down syndrome; Nuchal translucency; Screen positive rate; Triple test

Indexed keywords

BIOCHEMICAL MARKER;

ADULT; AMNIOCENTESIS; ARTICLE; CORRELATION FUNCTION; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NECK; PREGNANCY COMPLICATION; PRENATAL SCREENING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; SCREENING TEST; SECOND TRIMESTER PREGNANCY;

ADULT; BIOLOGICAL MARKERS; DOWN SYNDROME; FEMALE; FETAL DISEASES; HUMANS; MASS SCREENING; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; ULTRASONOGRAPHY, PRENATAL;

EID: 0033752266     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0223(200010)20:10<781::AID-PD908>3.0.CO;2-Z     Document Type: Article

References (25)

1. Comparison between two methods of standardization for gestational age differences in fetal nuchal translucency measurement in first-trimester screening for trisomy 21
2. Editorial. Performing screening for Down's syndrome - A search for the family's values
3. Calculating correct Down's syndrome risks
4. Maternal serum alpha-fetoprotein measurement: A screening test for Down's syndrome
5. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level
6. Commentary. Antenatal screening for Down's syndrome: Where are we and where next?
7. Prenatal screening for Down's syndrome with use of maternal serum markers
8. Results of routine fetal nuchal translucency measurement at weeks 10-13 in 4233 unselected pregnant women
9. Nuchal translucency audit: A novel image scoring method
10. The effect of nuchal translucency measurement on second-trimester biochemical screening for Down's syndrome
11. First-trimester nuchal translucency and second-trimester serum screening for Down's syndrome
12. Screening for Down syndrome in the second trimester of pregnancy
13. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities
14. Fetal nuchal translucency: Ultrasound screening for chromosomal defects in first trimester of pregnancy
15. First-trimester screening for fetal aneuploidy: Biochemistry and nuchal translucency
16. Recommendations of the 32nd Study Group of the Royal College of Obstetricians and Gynaecologists
17. Maternal age-specific risks for trisomies at 9-14 weeks' gestation
18. First-trimester ultrasound screening for chromosomal defects
19. UK multicenter project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation
20. Increased nuchal translucency as a marker for feral chromosomal defects
21. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome
22. Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome
23. Maternal serum unconjugated oestriol as a screening test for Down's syndrome
24. Antenatal maternal serum screening for Down's syndrome: Results of a demonstration project
25. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters